Live Breaking News & Updates on Materials Chemist Professor

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19
Apr 16 2021
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.
Image Credit: University of Liverpool
In a paper published in the journal
Nanoscale, researchers from the University’s Centre of Excellence for Long-acting Therapeutics (CELT) demonstrate the nanoparticle formulation of niclosamide, a highly insoluble drug compound, as a scalable long-acting injectable antiviral candidate.
The team started repurposing and reformulating identified drug compounds with the potential for COVID-19 therapy candidates within weeks of the first lockdown. Niclosamide is just one of the drug compounds identified and has been shown to be highly effective against SARS-CoV-2 in a number of laboratory studies. ....

United Kingdom , Steve Rannard , Andrew Owen , University Centre Of Excellence , University Of Liverpool , Image Credit , Long Acting Therapeutics , Professor Andrew Owen , Professor Steve Rannard , Materials Chemist Professor , Pharmacologist Professor , Clinical Pharmacology , British Journal , Drug Delivery , Ars Cov 2 , ஒன்றுபட்டது கிஂக்டம் , ஆண்ட்ரூ ஓவந் , பல்கலைக்கழகம் மையம் ஆஃப் சிறப்பானது , பல்கலைக்கழகம் ஆஃப் லிவர்பூல் , படம் கடன் , நீண்டது நடிப்பு சிகிச்சை , ப்ரொஃபெஸர் ஆண்ட்ரூ ஓவந் , மருத்துவ மருந்தியல் , பிரிட்டிஷ் இதழ் ,